Overview Fundamentals API Earnings EOD API Sample Code Pricing

Celyad Oncology SA (CLYYF PINK) stock market data APIs

$0.25 0(0%) as of July 22, 2024
Price chart is built with Anychart

Celyad Oncology SA, a biopharmaceutical company, focuses on the research and development of chimeric antigen receptor T (CAR-T) cell therapies for the treatment of cancer. The company is developing shRNA non-gene-edited technology, which allows for the development of allogenic CAR T-cells through the modulation of genes encoding the TCR without the need for gene editing; multi-specific CAR T-cell platform that focuses on the NKG2D receptor; NKG2D-based CAR T-cell therapies; and B7-H6 targeting CAT T-cell therapies. It has licensing agreement with Novartis International AG regarding the United States patents related to allogeneic CAR-T cells; and research and development collaboration, and license agreements with Horizon Discovery/PerkinElmer for the use of its shRNA reagents to reduce expression of one or more defined targets. The company was formerly known as Celyad SA and changed its name to Celyad Oncology SA in June 2020. Celyad Oncology SA was founded in 2004 and is headquartered in Mont-Saint-Guibert, Belgium.

Celyad Oncology SA Financial Data Overview

11 923 K
41 429 K
102 K
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'CLYYF',
Type: 'Common Stock',
Name: 'Celyad Oncology SA',
Exchange: 'PINK',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG00BNY0WB2',
CIK: '1637890',
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: NULL,
IsDelisted: false,

Celyad Oncology SA Fundamental Data is available in our Financial Data APIs

  • Net Revenue 102 K
  • EBITDA -9 004 000
  • Earnings Per Share -1.48
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get Celyad Oncology SA Earnings via APIs

  • Latest Release 2021-09-30
  • EPS/Forecast 0

Get Celyad Oncology SA End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?